Form 8-K - Current report:
SEC Accession No. 0001193125-13-438260
Filing Date
2013-11-12
Accepted
2013-11-12 16:10:59
Documents
3
Period of Report
2013-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d625657d8k.htm 8-K 15540
2 EX-99.1 d625657dex991.htm EX-99.1 40978
3 GRAPHIC g625657g57p52.jpg GRAPHIC 11434
  Complete submission text file 0001193125-13-438260.txt   73507
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36070 | Film No.: 131210271
SIC: 2834 Pharmaceutical Preparations